Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2015

Jan 5, 2015

30016_dirs_2015-01-05_cd5d9291-7413-4e34-9f16-4a42a3448120.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-01-01

Reporting Person: MCKEON BRIAN P (Executive VP, CFO & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-01 Common Stock M 1411 Acquired 13752 Direct
2015-01-01 Common Stock F 493 $148.27 Disposed 13259 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-01-01 Restricted Stock Unit $ M 1411 Disposed Common Stock (1411) Direct

Footnotes

F1: Represents restricted stock units previously granted on 01/01/2014 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary of the date of grant (01/01/2015).